🇺🇸 Fluticasone Diskus in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Influenza Like Illness — 2 reports (18.18%)
  2. Arthralgia — 1 report (9.09%)
  3. Drug Ineffective — 1 report (9.09%)
  4. Enterococcal Infection — 1 report (9.09%)
  5. Erythema — 1 report (9.09%)
  6. Escherichia Sepsis — 1 report (9.09%)
  7. Feeling Hot — 1 report (9.09%)
  8. Inflammation — 1 report (9.09%)
  9. Neuralgia — 1 report (9.09%)
  10. Pain In Extremity — 1 report (9.09%)

Source database →

Fluticasone Diskus in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fluticasone Diskus approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fluticasone Diskus in United States?

Johns Hopkins University is the originator. The local marketing authorisation holder may differ — check the official source linked above.